Amphastar Pharmaceuticals, Inc.
NASDAQ:AMPH · NASDAQ Global Select
-$0.31 today
Vol 1.26M · Avg 0.59M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-23.41%
Period High
$30.81
Period Low
$16.87
Latest
$18.81
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Dynavax Technologies Corporation
DVAX
$1.82B
Syndax Pharmaceuticals, Inc.
NASDAQ:SNDX
$1.70B
Harrow Health, Inc.
NASDAQ:HROW
$1.57B
Inhibrx Biosciences, Inc.
NASDAQ:INBX
$1.35B
AdaptHealth Corp.
NASDAQ:AHCO
$1.30B
Collegium Pharmaceutical, Inc.
NASDAQ:COLL
$1.08B
CureVac N.V.
CVAC
$1.05B
Pacira BioSciences, Inc.
NASDAQ:PCRX
$883.86M
Beta Bionics, Inc.
NASDAQ:BBNX
$605.59M
Embecta Corp.
NASDAQ:EMBC
$184.00M
What is the latest AMPH filing?
The latest filing shown is 4 dated Jun 3, 2026.
How many recent filings does AMPH have?
Intrinsic Alpha currently shows 20 recent filings for AMPH.
Explore More
Continue the stock analysis
Jump to another research area for this company.